An international pharmaceutical firm headquartered in the United States was in the planning stages of launching a campaign to bring advanced wound care to developing nations. To determine the viability of the program, the firm wanted to first know what the competition was doing in this area.

Intelex conducted a benchmarking study of the firms top three competitors in seven developing countries, including India and Mexico. The study was structured to reveal what these competitors were doing in those countries at that time and what their future plans might be.

Intelex was able to show that the firm's top three competitors were not bringing advanced biologic dressings and other forms of advanced wound care to developing nations. Intelex was also able to document one of the competition's efforts in this area and why continued efforts were abandoned. Because of Intelex's research, the client decided not to move forward, at that time, with the planned program.